Lumos Pharma Inc logo

Lumos Pharma Inc

$ 8.82 -0.23 (-2.54%) 04:00 PM EST
P/E:
At Loss
P/B:
0.99
Market Cap:
$ 74.05M
Enterprise V:
$ -7.16M
Volume:
52.36K
Avg Vol (2M):
8.31K
Also Trade In:
Volume:
52.36K
Market Cap $:
74.05M
PE Ratio:
At Loss
Avg Vol (2-Month):
8.31K
Enterprise Value $:
-7.16M
PB Ratio:
0.99
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates primarily in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 201.29
Equity-to-Asset 0.87
Debt-to-Equity 0.01
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.35
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 64.47
9-Day RSI 63.05
14-Day RSI 60.91
6-1 Month Momentum % -8.99
12-1 Month Momentum % -12.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 17.59
Quick Ratio 17.59
Cash Ratio 16.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.4

Financials (Next Earnings Date:2022-11-03 Est.)

LUMO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LUMO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.734
EPS (TTM) ($) -3.44
Beta 1.26
Volatility % 53.96
14-Day RSI 60.91
14-Day ATR ($) 0.369933
20-Day SMA ($) 8.751355
12-1 Month Momentum % -12.41
52-Week Range ($) 6.1501 - 10.575
Shares Outstanding (Mil) 8.4

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lumos Pharma Inc Filings

Document Form Filing Date
No Filing Data

Lumos Pharma Inc Analysis

Share your research

Headlines

See More
No news.